Experimental Hematology
Volume 38, Issue 5 , Pages 392-402.e1, May 2010

Tyrosine phosphorylation of SHIP promotes its proteasomal degradation

  • Jens Ruschmann

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
    • Fachbereich Biologie, Chemie, Pharmazie, Freie Universität-Berlin, Berlin, Germany
  • ,
  • Victor Ho

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
  • ,
  • Frann Antignano

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
  • ,
  • Etsushi Kuroda

      Affiliations

    • Department of Immunology and Parasitology, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
  • ,
  • Vivian Lam

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
  • ,
  • Mariko Ibaraki

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
  • ,
  • Kim Snyder

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
  • ,
  • Connie Kim

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
  • ,
  • Richard A. Flavell

      Affiliations

    • Department of Immunobiology, Yale University, School of Medicine and the Howard Hughes Medical Institute, New Haven, Conn., USA
  • ,
  • Toshiaki Kawakami

      Affiliations

    • Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, Calif., USA
  • ,
  • Laura Sly

      Affiliations

    • Department of Pediatrics, Division of Gastroenterology, BC Children's Hospital and University of British Columbia, Vancouver, BC, Canada
  • ,
  • Ali G. Turhan

      Affiliations

    • NSERM U935, Université de Poitiers and Service d'Hématologie et d'Oncologie Biologique, CHU de Poitiers, Poitiers, France
  • ,
  • Gerald Krystal

      Affiliations

    • The Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, BC, Canada
    • Corresponding Author InformationOffprint requests to: Gerald Krystal, Ph.D., The Terry Fox Laboratory, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada

Received 2 March 2010; received in revised form 2 March 2010; accepted 8 March 2010. published online 22 March 2010.

Objective

The activity of the SH2-containing-phosphatidylinositol-5′-phosphatase (SHIP, also known as SHIP1), a critical hematopoietic-restricted negative regulator of the PI3 kinase (PI3K) pathway, is regulated in large part via its protein levels. We sought to determine the mechanism(s) involved in its downregulation by BCR-ABL and by interleukin (IL)-4.

Materials and Methods

We used Ba/F3p210-tetOFF cells to study the downregulation of SHIP by BCR-ABL and bone marrow−derived macrophages to study SHIP's downregulation by IL-4.

Results

We show herein that BCR-ABL downregulates SHIP, but not SHIP2 or PTEN, and this can be blocked with the Src kinase inhibitor PP2, which inhibits the tyrosine phosphorylation of SHIP, or with the proteasomal inhibitor MG-132. We also show, using anti-SHIP immunoprecipitates, that c-Cbl and Cbl-b are associated with SHIP and that BCR-ABL induces SHIP's polyubiquitination. This ubiquitination can be blocked with PP2, consistent with the tyrosine phosphorylation of SHIP acting as a signal for its ubiquitination. In bone marrow−derived macrophages, IL-4 also leads to the proteasomal degradation of SHIP but, unlike in Ba/F3p210-tetOFF cells, SHIP2 is also proteasomally degraded and the degradation of both inositol phosphatases can be prevented with PP2 or MG-132.

Conclusion

Our results suggest that SHIP protein levels can be reduced via BCR-ABL and/or Src family member-induced tyrosine phosphorylation of SHIP because this triggers its polyubiquitination and degradation within the proteasome.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00101-3

doi:10.1016/j.exphem.2010.03.010

Experimental Hematology
Volume 38, Issue 5 , Pages 392-402.e1, May 2010